Sensydia

Los Angeles, United States

Developer of a portable, point-of-care hemodynamic measurement system that uses proprietary sensor tech and machine learning to guide care.

$3.0M raised

Jun 2023

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Sensydia raised?

Sensydia has raised $3.0M in total funding. The most recent round was Grant. The last funding was announced in June 2023.

Who are Sensydia's investors?

Sensydia's investors include Colle Capital Partners, Frontier Venture Capital, National Heart, Lung and Blood Institute, Orlando Health Ventures.

Where is Sensydia headquartered?

Sensydia is headquartered in Los Angeles, United States.

What does Sensydia do?

Developer of a portable, point-of-care hemodynamic measurement system that uses proprietary sensor tech and machine learning to guide care.

What stage is Sensydia at?

Sensydia is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 5, 2023.

MLA

"Sensydia — Funding & Investors." VCBacked, June 5, 2023, https://www.vcbacked.co/company/sensydia. Accessed July 1, 2026.

APA

VCBacked. (2023). Sensydia — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/sensydia

Wikipedia (cite web)

{{cite web |title=Sensydia — Funding & Investors |url=https://www.vcbacked.co/company/sensydia |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 5, 2023.